Cargando…
Threat to Cefixime Treatment for Gonorrhea
Autores principales: | Yokoi, Shigeaki, Deguchi, Takashi, Ozawa, Tomomi, Yasuda, Mitsuru, Ito, Shin-ichi, Kubota, Yasuaki, Tamaki, Masayoshi, Maeda, Shin-ichi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828067/ https://www.ncbi.nlm.nih.gov/pubmed/17953118 http://dx.doi.org/10.3201/eid1308.060948 |
Ejemplares similares
-
Macrolide Resistance–associated 23S rRNA Mutation in Mycoplasma genitalium, Japan
por: Shimada, Yasushi, et al.
Publicado: (2011) -
Grepafloxacin Versus Cefixime as Single-Dose Therapy for Uncomplicated Gonorrhea in Women
por: Mroczkowski, T. F., et al.
Publicado: (1997) -
Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
por: Gianecini, Ricardo, et al.
Publicado: (2016) -
New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan
por: Deguchi, Takashi, et al.
Publicado: (2016) -
Open Study of the Safety and Efficacy of a Single Oral Dose of Cefixime for the Treatment of
Gonorrhea in Pregnancy
por: Miller, Joseph M.
Publicado: (1997)